机构:[1]Department of Neurology, Montreal General Hospital, Montreal, Quebec, Canada[2]Department of Neurology, Innsbruck Medical University, Innsbruck, Austria[3]Department of Neurosciences, UC San Diego, La Jolla, California, USA[4]Brain and Mind Centre, Sydney Medical School, Camperdown, Australia[5]Morton and Gloria Shulman Movement Disorders Clinic and the Edmond J. Safra Program in Parkinson’s Disease, Toronto Western Hospital, Toronto, Ontario, Canada[6]Rush University Medical Center, Chicago, Illinois, USA[7]Department of Neurobiology and Neurology, Xuanwu Hospital of Capital Medical University, Beijing, People’s Republic of China神经内科首都医科大学宣武医院[8]Klinik für Neurologie, UKSH, Campus Kiel, Christian-Albrechts-Universit?t, Kiel, Germany[9]University of California, San Francisco, CA, USA
Background: In 2015, the International Parkinson and Movement Disorder Society published clinical diagnostic criteria for Parkinson's disease. These criteria aimed to codify/reproduce the expert clinical diagnostic process and to help standardize diagnosis in research and clinical settings. Their accuracy compared with expert clinical diagnosis has not been tested. The objectives of this study were to validate the International Parkinson and Movement Disorder Society diagnostic criteria against a gold standard of expert clinical diagnosis, and to compare concordance/accuracy of the International Parkinson and Movement Disorder Society criteria to 1988 United Kingdom Brain Bank criteria. Methods: From 8 centers, we recruited 626 parkinsonism patients (434 PD, 192 non-PD). An expert neurologist diagnosed each patient as having PD or non-PD, regardless of International Parkinson and Movement Disorder Society criteria (gold standard, clinical diagnosis). Then a second neurologist evaluated the presence/absence of each individual item from the International Parkinson and Movement Disorder Society criteria. The overall accuracy/concordance rate, sensitivity, and specificity of the International Parkinson and Movement Disorder Society criteria compared with the expert gold standard were calculated. Results: Of 434 patients diagnosed with PD, 94.5% met the International Parkinson and Movement Disorder Society criteria for probable PD (5.5% false-negative rate). Of 192 non-PD patients, 88.5% were identified as non-PD by the criteria (11.5% false-positive rate). The overall accuracy for probable PD was 92.6%. In addition, 59.3% of PD patients and only 1.6% of non-PD patients met the International Parkinson and Movement Disorder Society criteria for clinically established PD. In comparison, United Kingdom Brain Bank criteria had lower sensitivity (89.2%, P=0.008), specificity (79.2%, P=0.018), and overall accuracy (86.4%, P<0.001). Diagnostic accuracy did not differ according to age or sex. Specificity improved as disease duration increased. Conclusions: The International Parkinson and Movement Disorder Society criteria demonstrated high sensitivity and specificity compared with the gold standard, expert diagnosis, with sensitivity and specificity both higher than United Kingdom Brain Bank criteria. (c) 2018 International Parkinson and Movement Disorder Society
基金:
This study was funded by the Michael J Fox
Foundation.
第一作者机构:[1]Department of Neurology, Montreal General Hospital, Montreal, Quebec, Canada[*2]Department of Neurology,L7-305 Montreal General Hospital, 1650 Cedar Avenue, Montreal,Canada H3G1A4
通讯作者:
通讯机构:[*1]Klinik für Neurologie, UKSH,Campus Kiel, Christian-Albrechts-Universit?t, Kiel, Germany[*2]Department of Neurology,L7-305 Montreal General Hospital, 1650 Cedar Avenue, Montreal,Canada H3G1A4
推荐引用方式(GB/T 7714):
Ronald B. Postuma,Werner Poewe,Irene Litvan,et al.Validation of the MDS clinical diagnostic criteria for Parkinson's disease[J].MOVEMENT DISORDERS.2018,33(10):1601-1608.doi:10.1002/mds.27362.
APA:
Ronald B. Postuma,Werner Poewe,Irene Litvan,Simon Lewis,Anthony E. Lang...&Daniela Berg.(2018).Validation of the MDS clinical diagnostic criteria for Parkinson's disease.MOVEMENT DISORDERS,33,(10)
MLA:
Ronald B. Postuma,et al."Validation of the MDS clinical diagnostic criteria for Parkinson's disease".MOVEMENT DISORDERS 33..10(2018):1601-1608